The Kjas Community Mourns The Loss Of A Cherished Resident

YT Industries is returning under the ownership of its founder, Markus Flossmann, after he repurchased the brand following its financial difficulties. After the company entered into self ...

The Kjas Community Mourns the Loss of a Cherished Resident 1 Exclusive Content Member Only — Sign Up Free 🔒 Unlock full images & premium access

YT Industries has resumed trading in the UK for the first time since it entered into self-administration in July of last year. CEO Markus Flossmann bought the brand back from administrators in ...

Post Independent Citizen Telegram: Community profile: When an accident becomes the perfect outcome

“With every negative, there’s always a ton of positives,” says Kaleb Cook, the community and therapeutic recreation supervisor for Glenwood Springs. The 22-year-old supervisor came to Colorado and got ...

The Kjas Community Mourns the Loss of a Cherished Resident 4 Exclusive Content Member Only — Sign Up Free 🔒 Unlock full images & premium access

Post Independent Citizen Telegram: Community Profile: ‘I was meant to be a teacher’

What is a Community Health Profile? A community health profile uses publicly available existing data to describe the health of a neighborhood or community. The data used are often called "indicators" ...

Skye Bioscience is rated Buy, driven by nimacimab’s strong safety, durable weight-loss profile, and upcoming Phase 2a results. SKYE’s nimacimab targets the expanding anti-obesity market, showing ...

Medical Xpress: Loss of microbiota alters the profile of cells that protect the intestinal wall, experiments reveal

Loss of microbiota alters the profile of cells that protect the intestinal wall, experiments reveal

Eli Lilly (LLY) shares traded flat on Thursday as J.P. Morgan argued that adverse events overshadowed a potentially best-in-class weight loss profile indicated for its next-gen obesity therapy, ...

MSN: Eli Lilly confirms 'superior weight loss' of its next-generation obesity drug

The Kjas Community Mourns the Loss of a Cherished Resident 11 Exclusive Content Member Only — Sign Up Free 🔒 Unlock full images & premium access

Eli LillyLLY reported late-stage study results Thursday that confirmed the "superior weight loss profile" of its next-generation obesity treatment, retatrutide. On average, diabetic patients taking a ...